FOLD logo

Amicus Therapeutics, Inc. (FOLD) Return On Assets

Annual ROA:

-7.18%+13.00%(+64.42%)
December 31, 2024

Summary

  • As of today, FOLD annual return on assets is -7.18%, with the most recent change of +13.00% (+64.42%) on December 31, 2024.
  • During the last 3 years, FOLD annual ROA has risen by +20.78% (+74.32%).
  • FOLD annual ROA is now -17.13% below its all-time high of -6.13%, reached on December 31, 2009.

Performance

FOLD ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDprofitability metrics

Quarterly ROA:

-4.85%-1.02%(-26.63%)
June 30, 2025

Summary

  • As of today, FOLD quarterly return on assets is -4.85%, with the most recent change of -1.02% (-26.63%) on June 30, 2025.
  • Over the past year, FOLD quarterly ROA has increased by +11.12% (+69.63%).

Performance

FOLD Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDprofitability metrics

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

FOLD ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+64.4%+69.6%
3Y3 Years+74.3%+85.2%
5Y5 Years+83.5%+86.5%

FOLD ROA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+75.3%-26.6%+84.4%
5Y5-Yearat high+83.5%-26.6%+86.6%
All-TimeAll-Time-17.1%+99.5%>-9999.0%+92.5%

FOLD ROA History

DateAnnualQuarterly
Jun 2025
-
-4.85%(-26.6%)
Mar 2025
-
-3.83%(+47.8%)
Dec 2024
-7.18%(+64.4%)
-7.34%(+46.7%)
Sep 2024
-
-13.78%(+13.7%)
Jun 2024
-
-15.97%(+19.7%)
Mar 2024
-
-19.90%(+2.9%)
Dec 2023
-20.18%(+30.5%)
-20.50%(+13.1%)
Sep 2023
-
-23.60%(+5.4%)
Jun 2023
-
-24.94%(+6.9%)
Mar 2023
-
-26.79%(+9.0%)
Dec 2022
-29.04%(-3.9%)
-29.45%(+5.2%)
Sep 2022
-
-31.06%(+5.4%)
Jun 2022
-
-32.85%(-4.3%)
Mar 2022
-
-31.51%(-9.3%)
Dec 2021
-27.96%(+12.3%)
-28.82%(-4.9%)
Sep 2021
-
-27.48%(+11.0%)
Jun 2021
-
-30.88%(+1.7%)
Mar 2021
-
-31.41%(+7.5%)
Dec 2020
-31.88%(+26.6%)
-33.95%(+6.3%)
Sep 2020
-
-36.24%(-1.2%)
Jun 2020
-
-35.81%(+8.5%)
Mar 2020
-
-39.13%(+7.6%)
Dec 2019
-43.46%(+11.8%)
-42.37%(-3.1%)
Sep 2019
-
-41.10%(+23.1%)
Jun 2019
-
-53.43%(-4.2%)
Mar 2019
-
-51.28%(-16.1%)
Dec 2018
-49.26%(-44.3%)
-44.16%(+0.2%)
Sep 2018
-
-44.26%(-19.3%)
Jun 2018
-
-37.11%(-9.4%)
Mar 2018
-
-33.93%(-2.2%)
Dec 2017
-34.14%(-66.0%)
-33.20%(-10.9%)
Sep 2017
-
-29.93%(-37.9%)
Jun 2017
-
-21.71%(+2.9%)
Mar 2017
-
-22.36%(-3.8%)
Dec 2016
-20.57%(+12.9%)
-21.55%(-7.4%)
Sep 2016
-
-20.07%(+6.7%)
Jun 2016
-
-21.52%(+4.7%)
Mar 2016
-
-22.58%(+7.6%)
Dec 2015
-23.63%
-24.45%(+15.0%)
Sep 2015
-
-28.78%(+32.7%)
DateAnnualQuarterly
Jun 2015
-
-42.76%(+16.1%)
Mar 2015
-
-50.94%(-2.5%)
Dec 2014
-40.84%(+18.6%)
-49.70%(+8.4%)
Sep 2014
-
-54.25%(+3.7%)
Jun 2014
-
-56.33%(+6.1%)
Mar 2014
-
-59.97%(+3.0%)
Dec 2013
-50.19%(+7.5%)
-61.82%(-1.9%)
Sep 2013
-
-60.69%(-5.8%)
Jun 2013
-
-57.34%(-19.6%)
Mar 2013
-
-47.94%(-4.3%)
Dec 2012
-54.24%(-11.4%)
-45.98%(+3.2%)
Sep 2012
-
-47.50%(-9.5%)
Jun 2012
-
-43.39%(+9.2%)
Mar 2012
-
-47.80%(+2.3%)
Dec 2011
-48.71%(+12.3%)
-48.91%(+13.8%)
Sep 2011
-
-56.74%(+10.7%)
Jun 2011
-
-63.55%(-1.9%)
Mar 2011
-
-62.36%(+3.6%)
Dec 2010
-55.51%(-805.5%)
-64.68%(-671.8%)
Sep 2010
-
-8.38%(-54.0%)
Jun 2010
-
-5.44%(+25.6%)
Mar 2010
-
-7.31%(-19.8%)
Dec 2009
-6.13%(+77.0%)
-6.10%(+86.5%)
Sep 2009
-
-45.04%(-20.6%)
Jun 2009
-
-37.36%(-18.4%)
Mar 2009
-
-31.55%(-20.2%)
Dec 2008
-26.60%(-0.3%)
-26.25%(-5.9%)
Sep 2008
-
-24.79%(+6.9%)
Jun 2008
-
-26.63%(+10.9%)
Mar 2008
-
-29.88%(+7.1%)
Dec 2007
-26.53%(+65.4%)
-32.17%(-29.3%)
Sep 2007
-
-24.88%(-51.1%)
Jun 2007
-
-16.47%(-83.6%)
Mar 2007
-
-8.97%(>-9900.0%)
Dec 2006
-76.72%(+35.6%)
0.00%(0.0%)
Sep 2006
-
0.00%(+100.0%)
Jun 2006
-
-17.42%(+50.0%)
Mar 2006
-
-34.83%(+33.3%)
Dec 2005
-119.20%(+32.3%)
-52.25%
Dec 2004
-176.08%(+87.0%)
-
Dec 2003
-1350.84%
-

FAQ

  • What is Amicus Therapeutics, Inc. annual return on assets?
  • What is the all-time high annual ROA for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. annual ROA year-on-year change?
  • What is Amicus Therapeutics, Inc. quarterly return on assets?
  • What is the all-time high quarterly ROA for Amicus Therapeutics, Inc.?
  • What is Amicus Therapeutics, Inc. quarterly ROA year-on-year change?

What is Amicus Therapeutics, Inc. annual return on assets?

The current annual ROA of FOLD is -7.18%

What is the all-time high annual ROA for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high annual return on assets is -6.13%

What is Amicus Therapeutics, Inc. annual ROA year-on-year change?

Over the past year, FOLD annual return on assets has changed by +13.00% (+64.42%)

What is Amicus Therapeutics, Inc. quarterly return on assets?

The current quarterly ROA of FOLD is -4.85%

What is the all-time high quarterly ROA for Amicus Therapeutics, Inc.?

Amicus Therapeutics, Inc. all-time high quarterly return on assets is 0.00%

What is Amicus Therapeutics, Inc. quarterly ROA year-on-year change?

Over the past year, FOLD quarterly return on assets has changed by +11.12% (+69.63%)
On this page